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The RNA-binding domain of the protein kinase DAI, the double-stranded RNA inhibitor of translation,
contains two repeats of a motif that is also found in a number of other RNA-binding proteins. This motif
consists of 67 amino acid residues and is predicted to contain a positively charged a helix at its C terminus.
We have analyzed the effects of equivalent single amino acid changes in three conserved residues distributed
over each copy of the motif. Mutants in the C-terminal portion of either repeat were severely defective,
indicating that both copies of the motif are essential for RNA binding. Changes in the N-terminal and central
parts of the motif were more debilitating if they were made in the first motif than in the second, suggesting that
the first motif is the more important for RNA binding and that the second motif is structurally more flexible.
When the second motif was replaced by a duplicate of the first motif, the ectopic copy retained its greater
sensitivity to mutation, implying that the two motifs have distinct functions with respect to the process of RNA
binding. Furthermore, the mutations have the same effect on the binding of double-stranded RNA and VA RNA,
consistent with the existence of a single RNA-binding domain for both activating and inhibitory RNAs.
The double-stranded RNA (dsRNA)-activated inhibitor of
translation, DAI (also termed PKR, p68, DsI, and P1/eIF-2
kinase), is a cellular protein kinase that plays important roles
in growth control (18, 31), the induction of apoptosis (21), and
the interferon-induced host antiviral response pathway (re-
viewed in reference 24). Activation of DAI unmasks its ability
to phosphorylate the a subunit of eukaryotic initiation factor 2
(eIF-2), leading to the inhibition of translation (reviewed in
references 13, 34, and 35). During the initiation of protein
synthesis, eIF-2 is responsible for bringing the initiator tRNA
(Met-tRNAi) to the 40S ribosomal subunit, forming a 43S
Met-tRNAi complex. The transport of Met-tRNAi to the ribo-
some occurs by the formation of a ternary complex with eIF-2
and GTP. At the end of the initiation process, when the
mRNA and 60S ribosomal subunit have joined, eIF-2 is re-
leased in a binary complex with GDP. For eIF-2 to reenter the
initiation pathway, its associated GDP moiety must be ex-
changed for GTP. This recycling event is catalyzed by the
guanosine nucleotide exchange factor (also called eIF-2B).
When the a subunit of eIF-2 is phosphorylated on serine-51
(5), recycling fails because of the formation of a nondissociable
complex between the guanosine nucleotide exchange factor
and eIF-2(a)P (37). The failure of recycling results in a short-
age of eIF-2 zGTP and consequently the cessation of translation.
DAI is activated by a process that involves autophosphory-
lation and requires critical concentrations of dsRNA (6, 8, 19,
40). Two models have been proposed to explain the interac-
tions between DAI and dsRNA. The first model proposes that
DAI has one RNA-binding site and activation results from
intermolecular phosphorylation within a DAI dimer (19). At
limited RNA concentrations, two DAI molecules interact with
the same dsRNA molecule and intermolecular autophosphor-
ylation occurs; at higher RNA levels, however, the DAI mol-
ecules interact with the RNA individually and therefore are
unable to activate through intermolecular autophosphoryla-
tion. A second model proposes that activation of DAI involves
intramolecular phosphorylation and that there are two binding
sites for RNA on DAI, one for activation and one for inhibi-
tion (9). Under this model, RNA binds preferentially to the
activation site, leading to autophosphorylation; at higher RNA
concentrations, the RNA binds to both sites, preventing in-
tramolecular autophosphorylation.
DAI is fastidious about the dsRNA that can cause its acti-
vation. The RNA is usually perfectly duplexed, and if the
overall topology of the RNA is altered (by base modifications
or the intercalation of ethidium bromide), the ability of DAI to
bind RNA is lowered (1, 14, 32, 33). The affinity of DAI for
dsRNA increases as the length of the RNA duplex increases,
an optimum being reached at around 85 bp (22, 32). This
binding affinity correlates well with the ability of these dsRNAs
to activate DAI and also with a mobility shift change (22).
Shorter dsRNAs, though unable to activate DAI, can still in-
teract with the enzyme and inhibit DAI function at high
dsRNA concentrations (22, 32). A recently discovered excep-
tion is the RNA of hepatitis delta virus (38). This closed cir-
cular single-stranded RNA activates DAI even though it lacks
duplex regions longer than 20 bp.
The host antiviral defense mechanism serves to limit viral
proliferation. To thwart this defense mechanism, viruses have
evolved a number of different strategies that target DAI activ-
ity. One such strategy entails the synthesis of short, highly
structured, single-stranded RNAs which bind to DAI but do
not activate the enzyme. Such short RNAs, exemplified by
adenovirus-associated (VA) RNA, inhibit activation of DAI by
dsRNA that is apparently generated by symmetrical transcrip-
tion of the viral genome during infection (23). VA RNA is
produced throughout the viral life cycle, but it accumulates to
very high levels within the cell at the late stages of viral infec-
tion. It is these high levels of VA RNA that prevent DAI
activation (reviewed in reference 25). Other examples of vi-
ruses that produce small RNAs to inhibit DAI activation in-
clude human immunodeficiency virus type 1 (TAR RNA) and
Epstein-Barr virus (EBER RNA) (4, 11, 12). A wide variety of
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other techniques have been evolved by viruses to evade DAI
activation (reviewed in references 24 and 41).
Many proteins can bind RNA, and within these proteins, at
least nine types of RNA-binding motif have been identified
(26). Though the different motifs vary significantly, some
common elements include basic and/or aromatic amino acid
residues (17, 20). These residues are involved in electrostatic
interactions with the phosphate backbone of RNA and inter-
calation between the nucleotides of RNA. The RNA-binding
domain of DAI (Fig. 1A) is located in the first 171 amino acids
at the protein’s N terminus (7, 10, 16, 28, 36). This region
contains two repeats of a motif that is also found in a number
of other RNA-binding proteins, including the mouse DAI ho-
molog TIK, the Drosophila protein staufen, TAR RNA-bind-
ing protein 1, vaccinia virus E3L protein, Escherichia coli
RNase III, and the Xenopus proteins Xrlbpa and 4F (2, 10, 28,
42). Like DAI, many of the proteins that contain this motif
have multiple copies, up to five in staufen (42). Computer
analysis of published sequences for this motif has resulted in
the generation of a consensus sequence (42). Each copy of the
motif extends over about 67 residues (Fig. 1B) and contains a
positively charged putative a-helical region in the C-terminal
third of the motif (10, 28, 42). The motif is very well conserved
in the potentially a-helical region but exhibits lower levels of
conservation over the first two-thirds of its length (10, 42).
Furthermore, some copies of the motif maintain high levels of
homology within the helical region but display only limited
homology outside this region, raising the possibility that the
first two-thirds of the motif are less important for RNA binding
or perhaps are not part of the motif at all. As a result, it has
been proposed that there are two distinguishable kinds of
motif, a full-length motif and a short motif (42).
The two motifs in DAI represent a full-length motif and a
short motif (motifs 1 and 2, respectively). Deletion of either
copy of the motif from DAI greatly reduces binding, but simply
exchanging their locations in the molecule does not (mutant
Sub 2:1 [10]), indicating that the two copies are both required
but that their relative positions are less important. They do not
appear to be identical in function, however: whereas the sec-
ond motif can be replaced by a duplicate copy of the first motif,
a reciprocal construct containing tandem repeats of the second
motif displays only weak binding activity (10). Moreover, small
deletions and clustered point mutations in the first motif are
generally more debilitating than mutations in the second motif
(7, 10). These findings imply that the first copy of the motif is
more important for binding than the second, but it is difficult to
draw firm conclusions from these data since none of the mu-
tations tested were in equivalent residues in both copies of the
motif.
To define the motifs more precisely and to discern their
roles in RNA binding, we have mutated individual conserved
residues located in the left third, middle, and right third of the
motif, making identical mutations in both copies of the motif.
The results establish the significance of the motif as a whole for
binding both VA RNA and dsRNA and demonstrate that
although both motifs are required, the first motif appears to
make the more important interactions with the RNA. Further-
more, the mutations that we have introduced affect dsRNA
and VA RNA binding equally, supporting the hypothesis that
there is only one effective site for RNA binding rather than two
(one activating and one inhibitory).
MATERIALS AND METHODS
Construction of DAI mutants. Mutants SRG2DLS14 to -LS19 were prepared
by oligonucleotide-directed mutagenesis of the vector pUC118D and were trans-
ferred into SRG2DL (10) by exchange of HindIII-MscI DNA fragments. To
generate Sub 2:2*, which contains a deletion of motif 1 and a complete dupli-
cation of motif 2, pSRG2DL was digested with HindIII and NcoI to delete motif
1, and the resultant 39 recessed ends were filled by using T4 DNA polymerase
(New England Biolabs). Ligated between these sites was a 264-bp fragment that
encodes motif 2 in its entirety. This fragment was obtained by digestion of
SRG2DL with NcoI and BsaAI; its termini were also filled by using T4 DNA
polymerase. The translational start site of this construct corresponds to the
methionine at residue 98 of the original sequence. Construction of Sub 1:1 has
been described previously (10). The 1:1m, 1m:1, and 1m:1m series were prepared
in a similar manner after site-directed mutagenesis using the LS15 oligonucleo-
tide primer. All constructs were confirmed by DNA sequencing.
RNA synthesis and purification. Uncapped RNA was generated as previously
described (29) and used as a template for synthesis of truncated DAI. RNA was
purified by extraction with phenol and with chloroform-isoamyl alcohol (24:1).
The RNA was precipitated with ethanol, dissolved in TE (10 mM Tris-HCl [pH
7.4], 1 mM EDTA) and passed twice through Sephadex G-50 medium (Pharma-
cia) spin columns. The RNA was recovered by precipitation with ethanol and was
dissolved in TE.
Cell-free translation and RNA binding assays. The reactions were carried out
exactly as previously described (10). Briefly, proteins were synthesized in a wheat
germ translation system, using [35S]Met to label the proteins generated in vitro.
The proteins were then assayed in two kinds of RNA binding assay. The first
involved the immobilization of DAI as an immune complex on protein A-
Sepharose beads carrying polyclonal antibody to DAI. The ability of the mutant
proteins to retain synthetic, 32P-labeled dsRNA was measured by direct counting
and sodium dodecyl sulfate (SDS)-polyacrylamide gel analysis. In the second
assay, adenovirus type 2 VA RNAI was attached to CNBr-activated Sepharose
beads, and the ability of the 35S-labeled mutant DAI proteins to bind to this
matrix was determined by SDS-polyacrylamide gel analysis.
RESULTS
Equivalent mutations in the two motifs have differential
effects on RNA binding. The RNA-binding domain of DAI is
located in the N-terminal third of the protein, while the 11
kinase subdomains occupy the protein’s C-terminal half (7, 10,
16, 28, 30, 36, 44). The RNA-binding domain contains two
copies of a 67-amino-acid residue motif which is also present in
a number of other RNA-binding proteins (10, 28, 42). Limited
mutational data suggested that the first (N-terminal) copy of
this motif is more important than the second for RNA binding
(7, 10, 28). To test this conclusion rigorously, and to discover
whether both copies of the motif in their entirety are involved
in RNA binding, we constructed three pairs of mutants, mak-
ing identical changes in the two motifs (Fig. 1). The three
amino acids changed were chosen for their location and con-
servation. They are distributed across the entire motif, that is,
in its N terminus, center, and C terminus. Moreover, the mu-
tations are in highly conserved residues that are presumably
important for some functional aspect of the motif. Previous
experiments had shown that a truncated form of DAI, contain-
ing just the first 184 residues from the protein’s N terminus,
binds RNA as efficiently as does the full-length protein. There-
fore, the mutations were prepared in this truncated form of the
protein by cell-free transcription and translation, using T7
RNA polymerase and a wheat germ translation system. To
assay RNA binding, wild-type and mutant proteins were im-
mobilized by adsorption on protein A-Sepharose beads carry-
ing polyclonal antibody to DAI. The resultant complexes were
then exposed to 32P-labeled dsRNA, and the amount of bound
dsRNA was determined by direct estimation of radioactivity
(Fig. 2) and by gel electrophoresis (data not shown).
All of the mutations impaired RNA binding, but the mag-
nitude of the reduction varied dramatically depending both on
the position of the mutation in the RNA-binding motif and on
the motif which harbors the mutation. Changes in the highly
conserved a-helical region (LS16 and LS19) virtually abolished
binding whether the mutation was located in the first or second
copy of the motif. Changes in the central and N-terminal sites
reduced binding by an extent that ranged from 10 to 90%, but
changes in the second motif (LS17 and LS18) had less effect
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than the equivalent mutations in the first motif (LS14 and
LS15). Interestingly, the relative susceptibilities of the two
motifs to equivalent mutations were nonuniform. For example,
changing Ala to Gln at positions 19 and 110 in motifs 1 and 2
(LS14 and LS17) reduced binding to 20 and 45% of control
levels, respectively. On the other hand changing Phe to Ala at
residue 41 in motif 1 (LS15) was a severe mutation (10% of the
control level), but the equivalent change at residue 131 in the
second motif (LS18) was only slightly deleterious (90% of the
control level).
The same residues are involved in binding both dsRNA and
VA RNA. The experiments described above were conducted
with dsRNA of 85 bp, which is long enough to activate the
kinase optimally (22). To determine whether the binding of an
inhibitory RNA, VA RNAI, was affected to the same extent by
these mutations, we used an alternative assay. The immobi-
lized protein assay could not be used to examine the ability of
the mutant DAIs to bind VA RNA because of a nonspecific
VA RNA-binding protein that contaminates the immune com-
plex even when derived from an unprogrammed wheat germ
lysate (data not shown). Therefore, we measured the ability of
the 35S-labeled mutant proteins to bind to VA RNA covalently
attached to Sepharose beads (10). Complexes were analyzed by
SDS-polyacrylamide gel electrophoresis and autoradiography.
When the three pairs of mutants were assayed for their VA
RNA-binding capacities (Fig. 3), the results were similar to
FIG. 1. Structures of DAI and mutants. (A) Schematic representation of the linear wild-type DAI protein. The repeat of the RNA-binding domain is portrayed by
the large open boxes in the N terminus of the protein. The kinase catalytic domains are represented by the black boxes. The open box (S) indicates the putative
substrate-binding domain. (B) The amino acid sequence of each copy of the RNA-binding motif and the consensus sequence for this motif. The locations of the single
amino acid mutations used in this study are diagrammed. In the consensus sequence, identical or similar amino acids are shown in uppercase or lowercase, respectively.
The predicted a-helical region is underlined.
FIG. 2. Binding of dsRNA to DAI and DAI mutants. 32P-labeled dsRNA (85
bp) was adsorbed to 35S-labeled proteins immobilized on antibody-Sepharose
beads. The resultant RNA-protein complexes were analyzed by direct counting
of radioactivity: error bars represent the variation from seven different experi-
ments. WT, wild type;2VE, negative control (unprogrammed wheat germ trans-
lation).
360 GREEN ET AL. MOL. CELL. BIOL.
 o
n
 August 13, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
those obtained for dsRNA binding: mutations in the first motif
had a greater effect on VA RNA binding than equivalent
mutations in the second motif. Furthermore, each individual
mutation appeared to influence both VA RNA and dsRNA
binding to approximately the same extent, emphasizing the
importance of the predicted a helix and the different roles
played by the two copies of the motif in RNA binding. Thus, no
difference was apparent between an activating and an inhibi-
tory RNA.
Motif 2 cannot substitute for motif 1. These data suggest
that the second motif is less important for RNA binding than
the first. We had previously shown that a mutant DAI, Sub 2:2,
containing a deletion of motif 1 and a duplication of motif 2,
was severely debilitated (10). In this construct, however, the
spacing between the duplicated motifs was reduced by nine
amino acids, and the first three residues of the second repeat
were missing. Small deletions from the N terminus of motifs
from Xlrbp and staufen have been shown to reduce RNA
binding (42). Therefore, to determine if either of these two
features adversely influenced the binding properties of the
motif 2 repeat mutant, we constructed a further mutant, Sub
2:2*. This mutant contains two complete copies of motif 2 with
the alanine doublet in the middle of each motif (Fig. 1) sepa-
rated by 88 residues, instead of 90 residues as in wild-type DAI;
this slight decrease should be acceptable since a reduction of
four residues in the spacer region between motifs 1 and 2 had
no effect on RNA binding (mutant D5 [10]). The new mutant,
Sub 2:2*, was tested in both types of RNA binding assay to-
gether with the other mutants (Fig. 2 and Fig. 3, lane 8). The
truncated form of this protein is 208 residues, compared with
the 184 residues of the other proteins, which accounts for its
slower migration during electrophoresis. Like the original du-
plication of motif 2, Sub 2:2* bound dsRNA and VA RNA very
poorly, demonstrating that the second copy of the motif cannot
substitute for the first copy in DAI.
Motif 1 and motif 2 do not function analogously. From these
data and our previous work (10), it appears that there are
distinct functional differences between the two motifs con-
tained in the RNA-binding domain of DAI. The first motif is
more important for RNA binding, and it is less tolerant of
changes in its sequence. Given that motif 2, as a representative
of the so-called short domains (42), is homologous mainly at its
C terminus, it could be argued that a duplicate copy of motif 1
would be as permissive as motif 2 toward sequence changes. To
test this inference, we took advantage of the sharply different
responses of the motifs to the central mutation (Phe3Ala at
positions 41 and 131). As shown in Fig. 2, this mutation re-
duces binding to 10% of wild-type levels when located in the
motif 1 (LS15) but has very limited effect on RNA binding
when located in motif 2 (LS18). Since the replacement of the
second motif with a duplicate copy of the first motif (Sub 1:1)
also has little effect on RNA binding (10), we examined the
effect of introducing the Phe3Ala mutation into the different
copies of motif 1 in Sub 1:1. The three constructs generated for
this experiment are designated Sub 1m:1, Sub 1:1m, and Sub
1m:1m to indicate the introduction of the Phe3Ala mutation
within the first copy, second copy, or both copies of motif 1.
Figure 4A illustrates the constructs prepared for this experi-
ment in comparison with the wild-type molecule (1:2) and the
mutants, LS15 (1m:2) and LS18 (1:2m).
FIG. 3. Binding of VA RNA by DAI. Equal radioactive counts of [35S]Met-
labeled translation products for wild-type (WT) DAI and the mutants were
incubated with VA RNA-Sepharose beads. The resultant protein-RNA com-
plexes were analyzed by 20% polyacrylamide gel electrophoresis.
FIG. 4. Comparison of function between the two motifs. (A) Schematic representation of the constructs used in this experiment. (B) The RNA-binding assay was
carried out as described for Fig. 2; the results shown are for the mutants in panel A not described previously. WT, wild type.
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The abilities of these mutants to bind dsRNA are compared
in Fig. 4B. From these data, it is apparent that the conversion
of Phe to Ala in either the first or second copy of motif 1, or in
both copies, was severely detrimental to RNA binding. Thus,
motif 2 is not merely a degenerate copy of motif 1, in which
only the presumptive a-helical region is sufficient, nor is the
differential sensitivity of motif 1 and motif 2 simply a matter of
their relative positions in the molecule because Sub 1:1m is
much more severely affected by the mutations than LS18 (i.e.,
1:2m). Instead we are led to the conclusion that although motif
1 can functionally substitute for motif 2, the two motifs do not
bind RNA in the same manner since equivalent mutations
introduced into conserved residues in the two motifs exert
dramatically different effects on RNA binding even when they
occupy the same position in the protein molecule.
DISCUSSION
The RNA-binding domain of DAI comprises a 67-amino-
acid motif repeated twice (10, 28, 42). Although there is ho-
mology with a number of RNA-binding proteins across the
entire motif, most of the conserved residues are located in the
C terminus in a region that is predicted to form a positively
charged a-helix (10, 28, 42). This region represents a core
motif within the extended motif. In this study, the substitution
of proline for a highly conserved alanine residue within the
helix, thereby potentially disrupting the helical structure, pre-
vented RNA binding when the mutation was placed in either
copy of the motif. The significance of this Ala3Pro mutation
is twofold: first, it supports the view that the structure of the
helical region is essential for RNA binding; second, it estab-
lishes that two copies of the motif are indispensable for effi-
cient RNA binding since a single point mutation in either one
drastically reduces the RNA-binding property of the mutant
proteins. This result is in agreement with conclusions drawn
from previous work in which analysis of larger mutations had
indicated that both the charge and the structure of the helical
region were important for RNA binding (10).
While the Ala3Pro mutation in the C-terminal part of the
consensus has the most profound effect on RNA binding, giv-
ing over 95% inhibition, the other mutational sites studied,
distributed throughout the motif, also influence RNA binding.
This finding indicates that the entire motif is involved in RNA
binding, consistent with earlier results obtained with N- and
C-terminal deletions (42) and linker-scanning mutants (10).
However, the two motifs are not equally important for binding.
Changes at the two sites outside the C-terminal core had a
greater influence on RNA binding when placed in the first
motif than equivalent changes in the second motif, giving in-
hibitions of 80 to 90% compared with 10 to 50%. Furthermore,
a mutant DAI protein containing a deletion of motif 1 and a
duplication of motif 2 was severely debilitated, whereas the
reciprocal mutant containing a duplication of motif 1 binds
RNA nearly as efficiently as wild-type DAI (10). Not only do
the two motifs differ quantitatively in their relative importance
for binding, but there also appears to be a qualitative differ-
ence in their interactions with RNA. This functional difference
is illustrated by the contrasting effect of the substitution of
alanine for phenylalanine in the middle of the motif. Although
this residue is conserved in many copies of the motif (2, 10, 42),
the mutation had little effect when located in motif 2 (mutant
LS18, i.e., 1:2m) but reduced binding by at least 10-fold when
located in motif 1. The Phe3Ala change was severely detri-
mental in the wild-type molecule (LS15, i.e., 1m:2) and in the
context of the motif 1 duplication (1:1m, 1m:1, and 1m:1m).
This finding implies that the binding of RNA requires an intact
motif 1 but makes lesser demands on motif 2. The required
features of motif 2 appear to include its C-terminal potential a
helix but not all of the conserved residues located elsewhere in
the consensus sequence. However, the effects of substitutions,
especially combinations of substitutions, in the remaining two-
thirds of motif 2 show that this region does play some role in
RNA binding (10).
Results similar to those presented here were obtained when
the mutations that we have generated were studied for their
effects on DAI activity in yeast cells (39). This study demon-
strated a high correlation between the ability of mutations in
the RNA-binding domain to inhibit RNA binding in vitro and
to prevent the growth suppression phenotype caused by DAI in
yeast cells (39). Thus, some mutations in motif 1 permitted
yeast growth under conditions of DAI overexpression, but
none of the mutations in motif 2 had this effect, implying that
motif 1 is more important for RNA binding and consequently
DAI activity in vivo. The yeast system is extremely sensitive
and clearly revealed differences in activity between two
Ala3Pro mutations (LS16 and LS19), which were barely dis-
tinguishable in binding assays (39). Data presented here and
previously (10), summarized in Fig. 5, call attention to struc-
tural and functional distinctions between motifs 1 and 2. Motif
1 plays the more significant role in RNA binding, has the
higher level of homology to the RNA-binding motif consensus
sequence, and displays regions of functional importance that
are absent in motif 2. Although the greater importance of
motif 1 was postulated from previous studies (7, 10, 28), no
firm conclusions could be drawn because the mutations were
not made in identical residues in the two motifs. The functional
nonequivalence of the two motifs is consistent with the finding
that DAI mutants D1 and D2, containing deletions of motifs 1
and 2, respectively, complemented one another in yeast cells
(39). The requirement for both motifs seen here and in the
yeast experiments (39) are in disagreement with the results of
McCormack et al. (27). This group demonstrated the impor-
tance of the first motif by mutating one of the conserved lysine
residues in the a-helical region, but they reported that only
motif 1 is required for RNA binding (27). Since the constructs
used in these experiments were based on TrpE-DAI fusion
proteins, presumably the TrpE component of these fusion pro-
teins compensated in some way for the lack of motif 2.
How do we explain the differences between the first and
second motifs? One possible interpretation is that the two
similar motifs have evolved different functions within the
RNA-binding role. The first motif may make direct interac-
tions with RNA, while the second motif might be responsible
for presenting the first motif to the RNA. This possibility is
analogous to the function of two a helices in helix-turn-helix
motifs. Helix-turn-helix motifs are present in many DNA-bind-
ing proteins, such as the lambda repressor (15), and bind DNA
by inserting one helix (the recognition helix) into the major
groove of DNA. The second helix and the surrounding amino
acid residues are responsible for interactions with the DNA
backbone that hold the recognition motif in the correct orien-
tation (15). In the A-form configuration of dsRNA, the minor
groove is wide and easily accessible whereas the major groove
is too narrow to permit protein-RNA interactions (43). DAI
has been shown to interact with phosphate and hydroxyl
groups, both of which are located in the minor groove of RNA
(3). Possibly the first motif of DAI is responsible for direct
interactions with the minor groove of the RNA, while the
second motif stabilizes the first motif in the correct position
within the minor groove. It would follow that interactions be-
tween the first motif and RNA are the more critical and there-
fore that mutations in the first motif are more damaging than
362 GREEN ET AL. MOL. CELL. BIOL.
 o
n
 August 13, 2014 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
identical ones in the second motif. Since mutant 1:1, containing
a duplicate copy of motif 1 instead of motif 2, binds nearly as
well as the undisturbed molecule, it would be necessary to
suppose that motif 1 has retained the functions of motif 2 as
well as its own specific functions in RNA binding. Further-
more, more efficient binding of the domain swap mutant 2:1
than the wild-type molecule would imply considerable geomet-
rical plasticity in the cooperation between the two motifs.
An alternative and more attractive explanation for the dif-
ferences between the two motifs is that both motifs bind RNA,
but motif 2 performs this function less efficiently since it has
diverged further from the consensus sequence. Motif 1 may
form a compact, highly organized structure that makes a num-
ber of critical interactions along its entire length, so that mu-
tations in many sites within the motif affect RNA binding
adversely. Motif 2, on the other hand, may be a more flexible
structure interacting with RNA chiefly through its helical re-
gion, so that mutations elsewhere have a lesser or variable
effect. Presumably, the motifs function cooperatively in binding
RNA, and it is specific sequences in the N-terminal two-thirds
of the motif that prevent motif 1 from interacting with RNA
exclusively through its helical region, thereby giving rise to the
contrasting results seen between mutants 1:1m and 1:2m
(LS18). By the same token, the less important role of motif 2
in RNA binding may have led to its deviation from the con-
sensus sequence, especially in its N-terminal region. This
model satisfactorily accommodates the data obtained with do-
main swap and point mutants, both those in equivalent resi-
dues, presented here, and the clustered point mutants distrib-
uted less systematically through the motifs (10). In addition,
this view that both motifs interact with RNA is easier to rec-
oncile with their structural similarity and with the genetic ev-
idence of their ability to complement (39).
Notably, all seven mutations tested here altered the ability of
DAI to bind VA RNA and dsRNA to similar extents. In fact,
in all studies of the RNA-binding domain of DAI so far pub-
lished, no difference in VA RNA binding and dsRNA binding
has been detected. This suggests that the binding sites for the
two RNAs are identical or only subtly different. More extensive
mutagenesis is required to settle this point, but if, as it cur-
rently appears, the two RNAs do bind to the same region, then
the differentiation between RNAs which activate or inhibit
DAI must occur at a stage after RNA binding. A possible
interpretation of this finding is that the binding of DAI to
dsRNA results in a conformational change, such as the re-
moval of a pseudosubstrate site from the active site of the
kinase, permitting autophosphorylation and the activation of
eIF-2 kinase. Presumably, the compact highly structured form
of VA RNA does not permit the conformational change that
occurs upon binding to linear dsRNA (22), possibly because of
interactions between the enzyme and the complex stem-loop
structure that forms the central domain of the RNA and is
critical to its function (3, 25). Thus, VA RNA binds to DAI in
a nonproductive manner, thereby preventing dsRNA binding
and consequently inhibiting DAI activation.
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FIG. 5. Summary of RNA-binding abilities of the DAI mutants. The RNA-binding motifs of DAI are represented in the standard single-letter code. Residues that
are conserved in relation to the consensus sequence in Fig. 1 are shown in uppercase. Previously described mutations are shown below the motifs, and current mutations
are printed in reverse type above each motif. The effect of each mutation on RNA binding is indicated. The position of each mutation and the residues changed are
also shown.
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